|
Market Closed -
Nasdaq
16:00:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 2.110 USD | -2.31% |
|
-2.31% | -41.06% |
| 08-18 | Top Premarket Decliners | MT |
| 05-19 | Natural Alternatives International, Inc. Provides Earnings Guidance for Fourth Quarter and Full Year 2026 | CI |
| Market Cap | 15M 12.91M 12.12M 11.07M 20.79M 1.43B 20.94M 144M 55.9M 724M 56.31M 55.09M 2.4B | P/E 2024 |
-4.89x | P/E 2025 | -1.44x |
|---|---|---|---|---|---|
| Enterprise Value | 61.7M 53.13M 49.88M 45.54M 85.54M 5.87B 86.16M 591M 230M 2.98B 232M 227M 9.86B | EV / Sales 2024 |
0.75x | EV / Sales 2025 | 0.52x |
| Free-Float |
50.96% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.31% | ||
| 1 week | -2.31% | ||
| Current month | -7.86% | ||
| 1 month | -7.86% | ||
| 3 months | -16.27% | ||
| 6 months | -19.47% | ||
| Current year | -41.06% |
| 1 week | 2.07 | 2.36 | |
| 1 month | 2 | 2.44 | |
| Current year | 2 | 4.96 | |
| 1 year | 2 | 4.96 | |
| 3 years | 2 | 7.37 | |
| 5 years | 2 | 17.81 | |
| 10 years | 0 | 19.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark LeDoux
CEO | Chief Executive Officer | 72 | 1985-12-31 |
Kenneth Wolf
DFI | Director of Finance/CFO | 65 | 2026-05-14 |
Nancy Steely
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark LeDoux
CHM | Chairman | 72 | 2000-12-31 |
Alan Dunn
BRD | Director/Board Member | 71 | 2003-12-31 |
Laura Matherly
BRD | Director/Board Member | 62 | 2019-12-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/6/26 | Free | Director | 8,000 | 0.1295% | ||
| 3/6/26 | Tax | Chief Financial Officer | 20,151 | 0.3262% | ||
| 3/6/26 | Free | Director | 8,000 | 0.1295% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.31% | -2.31% | -41.87% | -65.97% | 13.24M | ||
| -1.52% | -7.23% | +57.90% | +108.72% | 1,031B | ||
| -0.82% | -2.63% | +50.05% | +64.43% | 641B | ||
| +0.37% | -3.06% | +21.87% | +74.48% | 453B | ||
| -1.64% | -4.75% | +35.59% | +35.54% | 349B | ||
| -0.39% | -2.76% | +21.39% | +38.01% | 290B | ||
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | ||
| -0.59% | -3.15% | +49.83% | +67.70% | 232B | ||
| -1.05% | -2.29% | -19.91% | -54.10% | 201B | ||
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | ||
| Average | -0.87% | -2.63% | +20.62% | +37.17% | 362.98B | |
| Weighted average by Cap. | -0.87% | -3.97% | +36.82% | +64.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 114M 97.98M 92M 83.98M 158M 10.83B 159M 1.09B 424M 5.49B 427M 418M 18.18B | 130M 112M 105M 95.83M 180M 12.36B 181M 1.24B 484M 6.27B 488M 477M 20.75B |
| Net income | -7.22M -6.21M -5.83M -5.33M -10.01M -687M -10.08M -69.14M -26.9M -348M -27.1M -26.51M -1.15B | -13.58M -11.69M -10.97M -10.02M -18.82M -1.29B -18.95M -130M -50.6M -655M -50.97M -49.86M -2.17B |
| Net Debt | 48.31M 41.59M 39.06M 35.65M 66.98M 4.6B 67.46M 463M 180M 2.33B 181M 177M 7.72B | 46.7M 40.21M 37.76M 34.47M 64.75M 4.44B 65.21M 447M 174M 2.25B 175M 172M 7.46B |
Employees
293
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-31 | US$2.110 | -2.31% | 3,815 |
| 26-08-28 | US$2.160 | -5.68% | 4,126 |
| 26-08-27 | US$2.290 | +5.53% | 198,981 |
| 26-08-26 | US$2.170 | -.--% | 4,402 |
| 26-08-25 | US$2.170 | +0.46% | 2,450 |
- Stock Market
- Stocks
- NAII Stock
Select your edition
All financial news and data tailored to specific country editions
















